The World Market for Unmixed Vitamins B and Derivatives: A 2022 Global Trade Perspective
This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for unmixed vitamins B and derivatives. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. Professor Philip M. Parker, the Chair Professor of Management Science at INSEAD, has developed a methodology, based on macroeconomic and trade models, to estimate the market for unmixed vitamins B and derivatives for those countries serving the world market via exports or supplying from various countries via imports. He does so for the current year based on a variety of key historical indicators and econometric models."Unmixed vitamins B and derivatives" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines "unmixed vitamins B and derivatives" is 54113.
- 1 METHODOLOGY
- 1.1 OUR APPROACH
- 2 THE WORLD MARKET
- 2.1 EXPORTS
- 2.1.1 THE WORLD MARKET: UNMIXED VITAMINS B AND DERIVATIVES EXPORT SUPPLIES IN 2022
- 2.2 IMPORTS
- 2.2.1 THE WORLD MARKET: IMPORTED UNMIXED VITAMINS B AND DERIVATIVES IN 2022
- 3 EXPORTS
- 3.1 AFRICA: EXPORT SUPPLIES OF UNMIXED VITAMINS B AND DERIVATIVES IN 2022
- 3.1.1 EXECUTIVE SUMMARY
- 3.1.2 ESWATINI
- 3.1.3 SOUTH AFRICA
- 3.2 ASIA: EXPORT SUPPLIES OF UNMIXED VITAMINS B AND DERIVATIVES IN 2022
- 3.2.1 EXECUTIVE SUMMARY
- 3.2.2 CHINA
- 3.2.3 HONG KONG
- 3.2.4 INDIA
- 3.2.5 INDONESIA
- 3.2.6 JAPAN
- 3.2.7 MALAYSIA
- 3.2.8 NORTH KOREA
- 3.2.9 SINGAPORE
- 3.2.10 SOUTH KOREA
- 3.2.11 TAIWAN
- 3.2.12 THAILAND
- 3.2.13 VIETNAM
- 3.3 EUROPE: EXPORT SUPPLIES OF UNMIXED VITAMINS B AND DERIVATIVES IN 2022
- 3.3.1 EXECUTIVE SUMMARY
- 3.3.2 AUSTRIA
- 3.3.3 BELARUS
- 3.3.4 BELGIUM
- 3.3.5 BULGARIA
- 3.3.6 DENMARK
- 3.3.7 FINLAND
- 3.3.8 FRANCE
- 3.3.9 GERMANY
- 3.3.10 HUNGARY
- 3.3.11 IRELAND
- 3.3.12 ITALY
- 3.3.13 LATVIA
- 3.3.14 LITHUANIA
- 3.3.15 NORWAY
- 3.3.16 POLAND
- 3.3.17 RUSSIA
- 3.3.18 SLOVAKIA
- 3.3.19 SPAIN
- 3.3.20 SWEDEN
- 3.3.21 SWITZERLAND
- 3.3.22 THE CZECH REPUBLIC
- 3.3.23 THE NETHERLANDS
- 3.3.24 THE UNITED KINGDOM
- 3.4 LATIN AMERICA: EXPORT SUPPLIES OF UNMIXED VITAMINS B AND DERIVATIVES IN 2022
- 3.4.1 EXECUTIVE SUMMARY
- 3.4.2 ARGENTINA
- 3.4.3 COLOMBIA
- 3.4.4 COSTA RICA
- 3.4.5 GUATEMALA
- 3.4.6 MEXICO
- 3.4.7 PANAMA
- 3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF UNMIXED VITAMINS B AND DERIVATIVES IN 2022
- 3.5.1 EXECUTIVE SUMMARY
- 3.5.2 CANADA
- 3.5.3 THE UNITED STATES
- 3.6 OCEANIA: EXPORT SUPPLIES OF UNMIXED VITAMINS B AND DERIVATIVES IN 2022
- 3.6.1 EXECUTIVE SUMMARY
- 3.6.2 AUSTRALIA
- 3.6.3 NEW ZEALAND
- 3.7 THE MIDDLE EAST: EXPORT SUPPLIES OF UNMIXED VITAMINS B AND DERIVATIVES IN 2022
- 3.7.1 EXECUTIVE SUMMARY
- 3.7.2 ISRAEL
- 3.7.3 TURKEY
- 4 IMPORTS
- 4.1 AFRICA: UNMIXED VITAMINS B AND DERIVATIVES IMPORTS IN 2022
- 4.1.1 EXECUTIVE SUMMARY
- 4.1.2 ALGERIA
- 4.1.3 EGYPT
- 4.1.4 ETHIOPIA
- 4.1.5 MALAWI
- 4.1.6 MOROCCO
- 4.1.7 NIGERIA
- 4.1.8 SOUTH AFRICA
- 4.1.9 TANZANIA
- 4.1.10 ZIMBABWE
- 4.2 ASIA: UNMIXED VITAMINS B AND DERIVATIVES IMPORTS IN 2022
- 4.2.1 EXECUTIVE SUMMARY
- 4.2.2 CHINA
- 4.2.3 HONG KONG
- 4.2.4 INDIA
- 4.2.5 INDONESIA
- 4.2.6 JAPAN
- 4.2.7 MALAYSIA
- 4.2.8 MONGOLIA
- 4.2.9 NEPAL
- 4.2.10 SINGAPORE
- 4.2.11 SOUTH KOREA
- 4.2.12 SRI LANKA
- 4.2.13 TAIWAN
- 4.2.14 THAILAND
- 4.2.15 THE PHILIPPINES
- 4.2.16 VIETNAM
- 4.3 EUROPE: UNMIXED VITAMINS B AND DERIVATIVES IMPORTS IN 2022
- 4.3.1 EXECUTIVE SUMMARY
- 4.3.2 AUSTRIA
- 4.3.3 BELARUS
- 4.3.4 BELGIUM
- 4.3.5 BOSNIA AND HERZEGOVINA
- 4.3.6 BULGARIA
- 4.3.7 CROATIA
- 4.3.8 CYPRUS
- 4.3.9 DENMARK
- 4.3.10 ESTONIA
- 4.3.11 FINLAND
- 4.3.12 FRANCE
- 4.3.13 GEORGIA
- 4.3.14 GERMANY
- 4.3.15 GREECE
- 4.3.16 HUNGARY
- 4.3.17 IRELAND
- 4.3.18 ITALY
- 4.3.19 KAZAKHSTAN
- 4.3.20 LATVIA
- 4.3.21 LITHUANIA
- 4.3.22 LUXEMBOURG
- 4.3.23 MACEDONIA
- 4.3.24 NORWAY
- 4.3.25 POLAND
- 4.3.26 PORTUGAL
- 4.3.27 ROMANIA
- 4.3.28 RUSSIA
- 4.3.29 SLOVAKIA
- 4.3.30 SLOVENIA
- 4.3.31 SPAIN
- 4.3.32 SWEDEN
- 4.3.33 SWITZERLAND
- 4.3.34 THE CZECH REPUBLIC
- 4.3.35 THE NETHERLANDS
- 4.3.36 THE UNITED KINGDOM
- 4.3.37 UKRAINE
- 4.4 LATIN AMERICA: UNMIXED VITAMINS B AND DERIVATIVES IMPORTS IN 2022
- 4.4.1 EXECUTIVE SUMMARY
- 4.4.2 ARGENTINA
- 4.4.3 BOLIVIA
- 4.4.4 BRAZIL
- 4.4.5 CHILE
- 4.4.6 COLOMBIA
- 4.4.7 ECUADOR
- 4.4.8 EL SALVADOR
- 4.4.9 GUATEMALA
- 4.4.10 HONDURAS
- 4.4.11 MEXICO
- 4.4.12 NICARAGUA
- 4.4.13 PANAMA
- 4.4.14 PARAGUAY
- 4.4.15 PERU
- 4.4.16 URUGUAY
- 4.5 NORTH AMERICA & THE CARIBBEAN: UNMIXED VITAMINS B AND DERIVATIVES IMPORTS IN 2022
- 4.5.1 EXECUTIVE SUMMARY
- 4.5.2 CANADA
- 4.5.3 THE DOMINICAN REPUBLIC
- 4.5.4 THE UNITED STATES
- 4.6 OCEANIA: UNMIXED VITAMINS B AND DERIVATIVES IMPORTS IN 2022
- 4.6.1 EXECUTIVE SUMMARY
- 4.6.2 AUSTRALIA
- 4.6.3 FIJI
- 4.6.4 NEW ZEALAND
- 4.7 THE MIDDLE EAST: UNMIXED VITAMINS B AND DERIVATIVES IMPORTS IN 2022
- 4.7.1 EXECUTIVE SUMMARY
- 4.7.2 ARMENIA
- 4.7.3 ISRAEL
- 4.7.4 JORDAN
- 4.7.5 KUWAIT
- 4.7.6 LEBANON
- 4.7.7 PAKISTAN
- 4.7.8 QATAR
- 4.7.9 TURKEY
- 5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
- 5.1 DISCLAIMERS & SAFE HARBOR
- 5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS